Abstract

Abstract CHO cell bioprocessing is a common application for producing biologics, antibodies, and proteins for therapeutic products. An important aspect of the CHO bioprocess is the characterization of a cell culture’s concentration and viability to ensure that the cells are in optimal condition for production. Traditionally, CHO cells have been measured using a manual hemocytometer or automated cell counter with trypan blue staining. However, these methods have limitations in throughput and instrument-to-instrument consistency. Here, we evaluate the performance of the Cellaca™ MX high-throughput cell counter for implementation into the CHO cell bioprocess. We investigate the precision, instrument-to-instrument consistency, linearity, and proportionality following ISO cell counting standard 20391-2:2019. We demonstrate close agreement between multiple Cellaca™ MX instruments using both CHO cells with Trypan Blue (5 instruments) and beads (32 instruments). We also report system-wide precision, which includes variation between multiple counts, consumables, instruments, and days (in the case of beads). Furthermore, we include the results of several comparison experiments in which samples were counted using Cellaca™ MX, hemocytometer, “Cell Counter V” (a competing instrument), as well as the Celigo® Imaging Cytometer. Finally, we demonstrate the use of the ISO cell counting standards to evaluate the linearity, precision, and proportionality index of the Cellaca™ MX. These results show that Cellaca™ MX can count trypan blue-stained CHO cells in brightfield in less than 1 min for 24 samples, and that the consistency, comparability, and precision of the Cellaca™ MX are significantly improved over the traditional methods.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.